SCHEMBL19425404

SCHEMBL19425404

COc1ccc(Cl)cc1Cc1cc(Cl)ccc1O

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 6/20 0.69
MEN1 O00255 5/20 0.69
HIF1A Q16665 3/20 0.69
CYP3A4 P08684 3/20 0.69
HPGD P15428 3/20 0.69
LMNA P02545 3/20 0.69
MAPT P10636 3/20 0.69
SMN1; SMN2 Q16637 3/20 0.69
ALOX15 P16050 2/20 0.69
USP2 O75604 2/20 0.69
IDO1 P14902 2/20 0.69
CASP1 P29466 2/20 0.69
SLC22A1 O15245 1/20 0.69
HSP90AA1 P07900 1/20 0.69
HSPD1 P10809 1/20 0.69
HSPA5 P11021 1/20 0.69
ALOX12 P18054 1/20 0.69
HTT P42858 1/20 0.69
BLM P54132 1/20 0.69
HSPE1 P61604 1/20 0.69

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19419865 0.92 KMT2A (0.59) KMT2AMEN1HIF1ACYP3A4HPGD
SCHEMBL12807760 0.92 KMT2A (0.59) KMT2AMEN1HIF1ACYP3A4HPGD
SCHEMBL12370675 0.89 IDO1 (0.50) KMT2AMEN1HIF1ACYP3A4HPGD
SCHEMBL19419880 0.86 MAPT (0.51) KMT2AMEN1HIF1ACYP3A4HPGD
Dichlorophen SCHEMBL29524636 0.83 CYP3A4 (1.00) KMT2AMEN1HIF1ACYP3A4HPGD
Dichlorophen SCHEMBL18052 0.83 CYP3A4 (1.00) KMT2AMEN1HIF1ACYP3A4HPGD
Dichlorophen SCHEMBL9109126 0.83 CYP3A4 (1.00) KMT2AMEN1HIF1ACYP3A4HPGD
Dichlorophen SCHEMBL29349447 0.83 CYP3A4 (1.00) KMT2AMEN1HIF1ACYP3A4HPGD
Dichlorophen SCHEMBL735904 0.81 CYP3A4 (0.95) KMT2AMEN1HIF1ACYP3A4HPGD
Dichlorophen SCHEMBL2471883 0.81 CYP3A4 (0.95) KMT2AMEN1HIF1ACYP3A4HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10195213-B2 Chemical entities that kill senescent cells for use in treating age-related disease UNITY BIOTECHNOLOGY, INC. (US) 2019-02-05 US disclosed
US-20170281649-A1 COMPOUNDS AND THERAPEUTIC USES UNITY BIOTECHNOLOGY, INC. 2017-10-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170281649-A1 COMPOUNDS AND THERAPEUTIC USES TP53, NQO1, SHMT2 KMT2A 3471/4885MEN1 3416/4885HIF1A 2724/4885
US-10195213-B2 Chemical entities that kill senescent cells for use in treating age-related disease TP53, CDKN1A, GLA KMT2A 2501/4885MEN1 2434/4885HIF1A 2497/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.